[{"NetIncomeLoss_1_Q1_USD":69119000.0,"Liabilities_0_Q1_USD":6077055000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":5125000.0,"EquityMethodInvestments_0_Q1_USD":444407000.0,"FinancingReceivableAllowanceForCreditLosses_0_Q1_USD":1556086000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q1_USD":89860000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":43156000.0,"RepaymentsOfLongTermDebt_1_Q1_USD":0.0,"CommitmentsAndContingencies_0_Q1_USD":null,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q1_USD":-4881000.0,"InterestPaidNet_1_Q1_USD":64500000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":29452000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":708810000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-599300000.0,"NotesAndLoansReceivableNetNoncurrent_0_Q1_USD":12599080000.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q1_USD":8272000.0,"DividendsCommonStockCash_1_Q1_USD":66000000.0,"AssetsCurrent_0_Q1_USD":2416024000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q1_shares":38000.0,"LongTermDebt_0_Q1_USD":5821072000.0,"LongTermDebtCurrent_0_Q1_USD":0.0,"OtherNoncashIncomeExpense_1_Q1_USD":-958000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_1_Q1_USD":17585000.0,"DebtInstrumentUnamortizedDiscount_0_Q1_USD":178928000.0,"ProceedsFromIssuanceOfLongTermDebt_1_Q1_USD":0.0,"ProvisionForLoanLossesExpensed_1_Q1_USD":35941000.0,"OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax_1_Q1_USD":0.0,"OtherAssetsNoncurrent_0_Q1_USD":4256000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":63634000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":2641000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q1_USD":583221000.0,"EarningsPerShareBasic_1_Q1_USD":0.18,"IncrementalCommonSharesAttributableToContingentlyIssuableShares_1_Q1_shares":217350000.0,"MinorityInterest_0_Q1_USD":4954818000.0,"EquitySecuritiesFvNiUnrealizedGainLoss_1_Q1_USD":-54186000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":607148000.0,"GainsLossesOnExtinguishmentOfDebt_1_Q1_USD":0.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":43000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":0.0,"EquityMethodInvestmentDividendsOrDistributions_1_Q1_USD":17325000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":5671000.0,"Revenues_1_Q1_USD":573027000.0,"InvestmentIncomeNet_1_Q1_USD":16598000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":-2207000.0,"InterestPayableCurrent_0_Q1_USD":10271000.0,"IncreaseDecreaseInOtherCurrentAssets_1_Q1_USD":-1939000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-226670000.0,"CostsAndExpenses_1_Q1_USD":343730000.0,"DerivativeAssetsNoncurrent_0_Q1_USD":2884000.0,"NotesReceivableNet_0_Q1_USD":13121468000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_1_Q1_USD":419783000.0,"OtherAssetsCurrent_0_Q1_USD":6657000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":69119000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q1_USD":179939000.0,"IncreaseDecreaseInOtherNoncurrentAssets_1_Q1_USD":0.0,"MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_1_Q1_USD":145378000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q1_USD":713000.0,"NotesReceivableGross_0_Q1_USD":14677554000.0,"IncomeLossFromEquityMethodInvestments_1_Q1_USD":-1918000.0,"PaymentsToAcquireFinanceReceivables_1_Q1_USD":503070000.0,"DilutiveSecuritiesEffectOnBasicEarningsPerShareOther_1_Q1_USD":38545000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":106494000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":158979000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":526100000.0,"ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_1_Q1_USD":15625000.0,"CommonStockDividendsPerShareCashPaid_1_Q1_USD":0.17,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":389760000.0,"DividendsCash_1_Q1_USD":65983000.0,"PaymentsToAcquireEquityMethodInvestments_1_Q1_USD":8714000.0,"TradingSecuritiesDebt_0_Q1_USD":1068913000.0,"PaymentsOfDebtIssuanceCosts_1_Q1_USD":0.0,"NonoperatingIncomeExpense_1_Q1_USD":-70318000.0,"InterestExpense_1_Q1_USD":37415000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":708810000.0,"LongTermDebtNoncurrent_0_Q1_USD":5821072000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q1_USD":107664000.0,"AdditionalPaidInCapital_0_Q1_USD":2931249000.0,"NotesAndLoansReceivableNetCurrent_0_Q1_USD":522388000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":9837033000.0,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":22995000.0,"ProvisionForLoanAndLeaseLosses_1_Q1_USD":292262000.0,"LiabilitiesCurrent_0_Q1_USD":255983000.0,"DueToRelatedPartiesCurrent_0_Q1_USD":108840000.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":505339000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-299870000.0,"TreasuryStockValue_0_Q1_USD":2359000.0,"FairValueAssetLiabilityRecurringBasisStillHeldUnrealizedGainLoss_1_Q1_USD":-54200000.0,"GainLossOnDerivativeInstrumentsNetPretax_1_Q1_USD":-2555000.0,"ProceedsFromInterestReceived_1_Q1_USD":1548000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":249200000.0,"Assets_0_Q1_USD":15914088000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":-10366000.0,"StockholdersEquityOther_1_Q1_USD":0.0,"ShareBasedCompensation_1_Q1_USD":713000.0,"DebtSecuritiesAvailableForSaleUnrealizedGainLoss_1_Q1_USD":9115000.0,"OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_1_Q1_USD":15491000.0,"EarningsPerShareDiluted_1_Q1_USD":0.18,"OperatingIncomeLoss_1_Q1_USD":229297000.0,"IncreaseDecreaseInInterestPayableNet_1_Q1_USD":-31875000.0,"FiniteLivedIntangibleAssetsGross_0_Q1_USD":606216000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":15914088000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":900000.0,"ProfitLoss_1_Q1_USD":158979000.0,"PaymentsToMinorityShareholders_1_Q1_USD":125721000.0,"UnrealizedGainLossOnDerivatives_1_Q1_USD":-2555000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":142706000.0,"TransferOfInvestments_1_Q1_USD":0.0,"AmortizationOfFinancingCostsAndDiscounts_1_Q1_USD":4790000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":1923771000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":69261000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q1_USD":58753000.0,"Ticker":"RPRX","CIK":"1802768","name":"ROYALTY PHARMA PLC","OfficialName":"Royalty Pharma plc Class A Ordinary Shares ","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"19213987432.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210511"}]